Infants Infected with Respiratory Syncytial Virus Generate Potent Neutralizing Antibodies that Lack Somatic Hypermutation.
Goodwin, E., Gilman, M.S.A., Wrapp, D., Chen, M., Ngwuta, J.O., Moin, S.M., Bai, P., Sivasubramanian, A., Connor, R.I., Wright, P.F., Graham, B.S., McLellan, J.S., Walker, L.M.(2018) Immunity 48: 339-349.e5
- PubMed: 29396163 
- DOI: 10.1016/j.immuni.2018.01.005
- Primary Citation of Related Structures:  
6APB, 6APC, 6APD - PubMed Abstract: 
Respiratory syncytial virus (RSV) is a leading cause of infant mortality, and there are currently no licensed vaccines to protect this vulnerable population. A comprehensive understanding of infant antibody responses to natural RSV infection would facilitate vaccine development ...